Replication of Oncology Randomized Trial Results using Swedish Registry Real World‐Data: A Feasibility Study-Reference-Cited by-同舟云学术

Replication of Oncology Randomized Trial Results using Swedish Registry Real World‐Data: A Feasibility Study

Author:

Jemielita Thomas¹,Widman Linnea²,Fox Claire³,Salomonsson Stina³,Liaw Kai‐Li³,Pettersson Andreas⁴⁵

Affiliation:

1. Biostatistics and Research Decision Sciences (BARDS) Merck & Co., Inc. Kenilworth New Jersey USA

2. Division of Biostatistics Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden

3. Center for Observational and Real‐World Evidence (CORE) Merck & Co., Inc. Kenilworth New Jersey USA

4. Clinical Epidemiology Division Department of Medicine Solna Karolinska Institutet Stockholm Sweden

5. Department of Pelvic Cancer, Cancer Theme Karolinska University Hospital Stockholm Sweden

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

Reference39 articles.

1. Framework for FDA's Real‐World Evidence Program.2018.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献